Latest News About - dental devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Saturday, January 20, 2018

8:30:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
ml
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Sean E Harper said: "The European Commission's approval of MVASI marks a significant milestone for both Amgen and the oncology community, providing a biosimilar for a medicine which is used across multiple types of cancer," External link

prnewswire Thursday, January 18, 2018 10:07:00 PM CET

David Nicholson said: "MVASI is the first product from our collaboration with Amgen to receive marketing authorization from the European Commission, highlighting the success of our joint commitment to developing cancer biosimilars," External link

prnewswire Thursday, January 18, 2018 10:07:00 PM CET

Group CEO said: “I believe our partnership with HealthTap will deliver truly innovative healthcare solutions to improve the lives of Bupa customers globally. We have decided to partner with HealthTap because of the combination of industry-leading technology, execution, and understanding of healthcare that HealthTap brings. Over the past year we have worked together to implement a number of solutions for day-to-day customer needs, such as easily finding local doctors covered by Bupa insurance, scheduling physiotherapy, immunisations, and doctor visits with local clinics, and connecting residents in our care homes with doctors by video chat. Together we bring world-leading digital health and care experiences to our customers, while saving costs, and delivering efficiencies for healthcare providers” External link

businesswire Thursday, January 18, 2018 2:29:00 AM CET

Paul Anderson said: “This is an important addition to our current global IP portfolio. Not only does it further strengthen our IP position in regenerative medicine products and surgical techniques for soft tissue repair, but it also acts to validate CelGro as a collagen medical device platform, for use across multiple indications including bone, tendons, peripheral nerves and aid in the repair of spinal cord injuries. This comes at a perfect time for the company as we move our products through the registration processes in the US” External link

4-traders Thursday, January 18, 2018 1:53:00 AM CET

Group CEO said: "I believe our partnership with HealthTap will deliver truly innovative healthcare solutions to improve the lives of Bupa customers globally. We have decided to partner with HealthTap because of the combination of industry-leading technology, execution, and understanding of healthcare that HealthTap brings. Over the past year we have worked together to implement a number of solutions for day-to-day customer needs, such as easily finding local doctors covered by Bupa insurance, scheduling physiotherapy, immunisations, and doctor visits with local clinics, and connecting residents in our care homes with doctors by video chat. Together we bring world-leading digital health and care experiences to our customers, while saving costs, and delivering efficiencies for healthcare providers" External link

marketwatch Wednesday, January 17, 2018 3:25:00 PM CET

David Mercado stated: "This partnership allows us to better support the rapidly evolving needs of our customers and accelerate innovation in the area of personalized medicine," External link

4-traders Wednesday, January 17, 2018 3:19:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.